Bactiguard Holding

Board/Management Information • Aug 28, 2017

Press release Stockholm 28 August, 2017

Bactiguard appoints new CFO

Bactiguard Holding AB (publ) has appointed Cecilia Edström, today Senior Vice President Sales and New Business, as acting Chief Financial Officer (CFO). She succeeds Fredrik Järrsten, who will leave Bactiguard to assume a new CFO role in another company. Cecilia Edström will assume her new position on 15 September.

"Fredrik Järrsten has been Bactiguard's CFO since the spring of 2014. Since then Bactiguard has been through a major transition, which started with the refinancing and IPO in June 2014. The financial infrastructure has been strengthened and the quality of the financial reporting improved, and in this process Fredrik has been instrumental. I would like to thank him for his valuable contribution to Bactiguard and wish him all the best in his new role", says Christian Kinch, CEO.

"Cecilia Edström is an experienced executive and leader, with strong business focus and broad competence from some of Sweden's major listed international companies. She has a solid financial background and her experience was a prerequisite for Bactiguard's IPO. She is already part of Bactiguard's executive management, with responsibility for new business development and international sales. I am pleased that we, with this solution, safeguard important competence and continuity in Bactiguard and pave the way for an optimal long term solution", Christian Kinch continues.

Cecilia Edström was previously a member of Group Management at Scania and TeliaSonera. She has a Bachelor of Science from the Stockholm School of Economics and joined the corporate finance team at SEB thereafter. She joined Bactiguard in the spring of 2014, initially with responsibility for communication and IR and to prepare the company for the IPO. As acting CFO, Cecilia Edström will maintain responsibility for new business development and Fredrik Järrsten will remain in the company a short period of time to ensure a smooth transition.

This information is information that Bactiguard Holding AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below 2017-08-28, at. 08.00

For further information, please contact:

Christian Kinch, CEO, tel: +46 8 440 58 80

Cecilia Edström, mobile: +46 72 226 23 28

About Bactiguard

Bactiguard is a Swedish medical device company with a mission to save lives. To achieve this mission we develop and supply infection protection solutions which reduce the risk of healthcare associated infections and the use of antibiotics. This way, we save significant costs for healthcare and the society at large.

The Bactiguard technology prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard offers the technology through licence agreements and our BIP (Bactiguard Infection Protection) portfolio of products. Through our licence partner CR Bard, urinary catheters with Bactiguard's coating are market leading in the USA and Japan. Bactiguard's own product portfolio of urinary catheters, endotracheal tubes and central venous catheters prevent some of the most common infections, which appear in the urinary tract, the blood stream and the respiratory tract.

Bactiguard is in a strong expansion phase in the European markets, China, India and the Middle East as well by establishing license agreements in new therapeutic areas. The company has about 60 employees around the world. Its headquarters and one of two production facilities are located in Stockholm, the other one in Malaysia. Bactiguard is listed on Nasdaq Stockholm.

Read more about how Bactiguard saves lives on www.bactiguard.com